339 related articles for article (PubMed ID: 29619517)
1. Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
Eur Radiol; 2018 Sep; 28(9):3819-3831. PubMed ID: 29619517
[TBL] [Abstract][Full Text] [Related]
2. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-Weighted Imaging and Diffusion Tensor Imaging for Differentiating High-Grade Glioma from Solitary Brain Metastasis: A Systematic Review and Meta-Analysis.
Suh CH; Kim HS; Jung SC; Kim SJ
AJNR Am J Neuroradiol; 2018 Jul; 39(7):1208-1214. PubMed ID: 29724766
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric MRI as a potential surrogate endpoint for decision-making in early treatment response following concurrent chemoradiotherapy in patients with newly diagnosed glioblastoma: a systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
Eur Radiol; 2018 Jun; 28(6):2628-2638. PubMed ID: 29374321
[TBL] [Abstract][Full Text] [Related]
5. Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.
Suh CH; Park JE; Jung SC; Choi CG; Kim SJ; Kim HS
Neuroradiology; 2019 May; 61(5):525-534. PubMed ID: 30666352
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
She D; Xing Z; Cao D
J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
[TBL] [Abstract][Full Text] [Related]
7. Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
Eur Radiol; 2019 Feb; 29(2):745-758. PubMed ID: 30003316
[TBL] [Abstract][Full Text] [Related]
8. Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis.
Choi SH; Jung SC; Kim KW; Lee JY; Choi Y; Park SH; Kim HS
J Neurooncol; 2016 Jun; 128(2):185-94. PubMed ID: 27108275
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis.
van Dijken BRJ; van Laar PJ; Holtman GA; van der Hoorn A
Eur Radiol; 2017 Oct; 27(10):4129-4144. PubMed ID: 28332014
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
[TBL] [Abstract][Full Text] [Related]
12. Relative percentage signal intensity recovery of perfusion metrics—an efficient tool for differentiating grades of glioma.
Smitha KA; Gupta AK; Jayasree RS
Br J Radiol; 2015 Aug; 88(1052):20140784. PubMed ID: 26110202
[TBL] [Abstract][Full Text] [Related]
13. The role of DSC MR perfusion in predicting IDH mutation and 1p19q codeletion status in gliomas: meta-analysis and technical considerations.
Siakallis L; Topriceanu CC; Panovska-Griffiths J; Bisdas S
Neuroradiology; 2023 Jul; 65(7):1111-1126. PubMed ID: 37173578
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.
Yu Y; Ma Y; Sun M; Jiang W; Yuan T; Tong D
Medicine (Baltimore); 2020 Jun; 99(23):e20270. PubMed ID: 32501974
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.
Anselmi M; Catalucci A; Felli V; Vellucci V; Di Sibio A; Gravina GL; Di Staso M; Di Cesare E; Masciocchi C
Neuroradiol J; 2017 Jun; 30(3):240-252. PubMed ID: 28627984
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Different Post-Processing Algorithms for Dynamic Susceptibility Contrast Perfusion Imaging of Cerebral Gliomas.
Kudo K; Uwano I; Hirai T; Murakami R; Nakamura H; Fujima N; Yamashita F; Goodwin J; Higuchi S; Sasaki M
Magn Reson Med Sci; 2017 Apr; 16(2):129-136. PubMed ID: 27646457
[TBL] [Abstract][Full Text] [Related]
18. Role of magnetic resonance spectroscopy to differentiate high-grade gliomas from metastases.
Wang Q; Zhang J; Xu W; Chen X; Zhang J; Xu B
Tumour Biol; 2017 Jun; 39(6):1010428317710030. PubMed ID: 28631566
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Susceptibility-Weighted Imaging and Dynamic Susceptibility Contrast Magnetic Resonance Imaging for Differentiating High-Grade Glioma from Primary Central Nervous System Lymphomas: Meta-Analysis.
Wu Y; Den Z; Lin Y
World Neurosurg; 2018 Apr; 112():e617-e623. PubMed ID: 29371168
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of MR diffusion kurtosis imaging for differentiating low-grade from high-grade glioma before surgery: A systematic review and meta-analysis.
Xu C; Li C; Xing C; Li J; Jiang X
Clin Neurol Neurosurg; 2022 Sep; 220():107373. PubMed ID: 35878557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]